AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers)

Therapeutic Areas

Cardiovascular DiseasesEndocrinology and Metabolic Disease

Active Indication

DyslipidemiasEssential HypertensionHypertension+ [1]

Inactive Indication-

Originator Organization

Chong Kun Dang Pharmaceutical Corp.

Active Organization

Chong Kun Dang Pharmaceutical Corp.

Inactive Organization-

License Organization-

Drug Highest PhaseApproved

First Approval Date

South Korea (21 Mar 2025),

DyslipidemiasEssential HypertensionHypertension+ [1]

Regulation-

Structure/Sequence

Molecular FormulaC22H28FN3O6S

InChIKeyBPRHUIZQVSMCRT-VEUZHWNKSA-N

CAS Registry287714-41-4

View All Structures (6)

R&D Status

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Dyslipidemias	South Korea	Chong Kun Dang Pharmaceutical Corp.	21 Mar 2025
Essential Hypertension	South Korea	Chong Kun Dang Pharmaceutical Corp.	21 Mar 2025
Hypertension	South Korea	Chong Kun Dang Pharmaceutical Corp.	21 Mar 2025
Primary hypercholesterolemia	South Korea	Chong Kun Dang Pharmaceutical Corp.	21 Mar 2025

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Hiro LS Researcher

The AI Search Engine Built to Accelerate Biopharma Decisions

Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.

Ask any biopharma research question→

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Discover Synapse Data Servers

Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis